🇺🇸 FDA
Pipeline program

AZD3514

D3760C00003

Phase 1 small_molecule completed

Quick answer

AZD3514 for Prostate Cancer is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca
Indication
Prostate Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials